Genomma Lab Internacional SAB De CV (LABB)

Currency in MXN
20.280
-0.330(-1.60%)
Delayed Data·
LABB Scorecard
Full Analysis
Trading at a low P/E ratio relative to near-term earnings growth
Earnings results expected in 5 days
Fair Value
Day's Range
20.27020.600
52 wk Range
16.98029.180
Key Statistics
Bid/Ask
20.28 / 20.30
Prev. Close
20.61
Open
20.45
Day's Range
20.27-20.6
52 wk Range
16.98-29.18
Volume
151.66K
Average Vol. (3m)
3.84M
1-Year Change
15.59%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
LABB Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
30.200
Upside
+48.92%
Members' Sentiments
Bearish
Bullish
ProTips
Valuation implies a strong free cash flow yield
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Genomma Lab Internacional SAB De CV Company Profile

Genomma Lab Internacional, S.A.B. de C.V., together with its subsidiaries, provides pharmaceutical and personal care products primarily in Mexico and internationally. It develops, sells, and markets a range of branded products in the categories of anti-acne products, self-diagnosis, antibacterial, cream to improve the texture of scarred skin, shampoos, dandruff shampoos, soaps, razors, products to prevent hair loss, ointment for muscle pain, anti-fungal treatments for the relief of colitis, products to counter stress levels, anti-wrinkles, antacids, anti-ulcers, anti-flu, protection and improvement products, treatments against hemorrhoids, against varicose veins, osteoarthritis, ophthalmic medications, infant nutrition, and others. Genomma Lab Internacional, S.A.B. de C.V. was incorporated in 1996 and is based in Mexico City, Mexico.

Employees
1624
Market
Mexico

Compare LABB to Peers and Sector

Metrics to compare
LABB
Peers
Sector
Relationship
P/E Ratio
9.3x14.0x−0.5x
PEG Ratio
0.100.010.00
Price / Book
1.8x1.3x2.6x
Price / LTM Sales
1.1x1.7x3.2x
Upside (Analyst Target)
45.6%7.2%43.8%
Fair Value Upside
Unlock23.2%5.1%Unlock

Analyst Ratings

3 Buy
2 Hold
0 Sell
Ratings:
5 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 30.200
(+48.92% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 2.18%
Dividend Yield
3.88%
Annualized Payout
0.80
Paid unevenly
5-Years Growth
-
Growth Streak

Earnings

Latest Release
Apr 30, 2025
EPS / Forecast
0.50 / 0.479
Revenue / Forecast
4.41B / 4.64B
EPS Revisions
Last 90 days

LABB Income Statement

People Also Watch

7.89
TLEVISACPO
0.00%
263.300
OMAB
-0.58%
194.32
AC
-0.57%
43.190
BBAJIOO
-0.94%
17.19
SITES1A1
+2.26%

FAQ

What Is the Genomma Lab Int (LABB) Stock Price Today?

The Genomma Lab Int stock price today is 20.28

What Stock Exchange Does Genomma Lab Int Trade On?

Genomma Lab Int is listed and trades on the Mexico Stock Exchange stock exchange.

What Is the Stock Symbol for Genomma Lab Int?

The stock symbol for Genomma Lab Int is "LABB."

Does Genomma Lab Int Pay Dividends? What’s The Current Dividend Yield?

The Genomma Lab Int dividend yield is 3.88%.

What Is the Genomma Lab Int Market Cap?

As of today, Genomma Lab Int market cap is 19.90B.

What Is Genomma Lab Int's Earnings Per Share (TTM)?

The Genomma Lab Int EPS (TTM) is 2.18.

When Is the Next Genomma Lab Int Earnings Date?

Genomma Lab Int will release its next earnings report on Jul 23, 2025.

From a Technical Analysis Perspective, Is LABB a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Genomma Lab Int Stock Split?

Genomma Lab Int has split 1 times.

How Many Employees Does Genomma Lab Int Have?

Genomma Lab Int has 1624 employees.

What is the current trading status of Genomma Lab Int (LABB)?

As of Jul 18, 2025, Genomma Lab Int (LABB) is trading at a price of 20.28, with a previous close of 20.61. The stock has fluctuated within a day range of 20.27 to 20.60, while its 52-week range spans from 16.98 to 29.18.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.